For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Apellis Pharmaceuticals Inc’s stock clocked out at $33.66, up 1.42% from its previous closing price of $33.19. In other words, the price has increased by $1.42 from its previous closing price. On the day, 5.35 million shares were traded. APLS stock price reached its highest trading level at $34.98 during the session, while it also had its lowest trading level at $32.71.
Ratios:
To gain a deeper understanding of APLS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.73 and its Current Ratio is at 4.36. In the meantime, Its Debt-to-Equity ratio is 1.98 whereas as Long-Term Debt/Eq ratio is at 1.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on November 21, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $31.
On October 25, 2024, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 11 ’24 when Watson David O. sold 5,000 shares for $34.23 per share. The transaction valued at 171,175 led to the insider holds 112,721 shares of the business.
DAVID OSBORNE WATSON bought 5,000 shares of APLS for $171,175 on Dec 11 ’24. On Sep 16 ’24, another insider, Dunlop A. Sinclair, who serves as the Director of the company, sold 37,000 shares for $36.23 each. As a result, the insider received 1,340,597 and left with 100,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 4187068416 and an Enterprise Value of 4253828864. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.93 while its Price-to-Book (P/B) ratio in mrq is 17.33. Its current Enterprise Value per Revenue stands at 5.948 whereas that against EBITDA is -19.204.
Stock Price History:
Over the past 52 weeks, APLS has reached a high of $73.80, while it has fallen to a 52-week low of $24.34. The 50-Day Moving Average of the stock is 13.57%, while the 200-Day Moving Average is calculated to be -15.12%.
Shares Statistics:
It appears that APLS traded 3.36M shares on average per day over the past three months and 3086760 shares per day over the past ten days. A total of 122.07M shares are outstanding, with a floating share count of 101.45M. Insiders hold about 18.44% of the company’s shares, while institutions hold 92.55% stake in the company. Shares short for APLS as of 1732838400 were 21811296 with a Short Ratio of 6.49, compared to 1730332800 on 20786277. Therefore, it implies a Short% of Shares Outstanding of 21811296 and a Short% of Float of 24.01.
